.Practice Precision Medicines has actually racked up an additional midphase win in epilepsy this yea...
.After escaping a professional grip numerous years back, Dyne Therapy has actually uncovered new per...
.Arrowhead Pharmaceuticals has actually presented its hand ahead of a potential face-off with Ionis,...
.Pfizer and Valneva may possess concerning 2 additional years to stand by prior to they make the fir...
.Let's dive into a talk along with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as...
.Bayer put on hold the phase 3 trial for its factor XIa inhibitor asundexian late in 2015 after the ...
.Sanofi is still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FDA, manage...
.Galapagos is coming under additional tension from financiers. Having developed a 9.9% risk in Galap...
.Accept to today's Chutes & Ladders, our roundup of notable leadership hirings, firings and also ...
.Shanghai Allist Pharmaceuticals has actually gotten itself a starring character in China's KRAS mar...